Oncology

Eight genes expressed in glioblastoma tumors that can predict the survival time of the patient.

Robotic trainer rectum helps teach providers to better detect prostate cancer.

Hops could lower risk of breast cancer in post-menopausal women.

Patient navigators found to enhance adherence to screening guidelines in ethnic minority and less fortunate cancer patients.

Female mice with obese fathers have delayed development in breast tissue and higher rates of breast cancer.

Multiple myeloma cells show greater ability to spread in obese and morbidly obese patients.

Top news of the day from across the health care landscape.

Discovery may lead to new treatments for colon cancer.

Surgeons were able to remove 29% of additional tumors using OTL38.

Patients with increased PSA levels had a 71 to 86% higher risk of developing prostate cancer.

US cancer centers spent $173 million on advertising in 2014.

Avelumab is an experimental, full human anti-PD-L1 Ig G1 monoclonal antibody.

Mole rats are remarkably resistant to cancer.

UM-164 blocks the c-Src kinase that plays a role in the growth and spread of breast cancer.

Sutent is an oral multi-kinase inhibitor originally approved by the FDA in 2006.

Study finds disparities in cancer survival independent of socioeconomic status.

Cutting cancer cells off from nutrients resulted in a 96% reduction in growth.

CD40-antibody drugs could have enhanced anti-tumor activity.

Drug efficacy varies in colorectal cancer dependent on where the tumor is located.

Certain bacterial populations are increased or decreased in the presence of cancer.

After breast cancer surgery, patients who received non-opiate analgesia used less painkilling medication than patients who received opiate analgesia.

A majority of patients with specific gene mutation will eventually relapse and die of treatment-resistant leukemia.

Genetic changes to BRCA1 predicts higher risk of breast and ovarian cancers.

Treating modifiable risk factors could enhance breast cancer prevention.

Anti-nausea and vomit medication could help reduce hospitalization in liver cancer.

Recent advances and updates in oncology and cancer drug development.

Patients receiving radiotherapy twice per day had a 2-year survival of 56% versus 51% in patients receiving treatment once per day.

MEDI4736 is an experimental human monoclonal antibody used against PDL1.